Outcomes of a multidisciplinary team approach to cardiovascular risk reduction in patients with diabetes mellitus

Author： Taylor Angela M   McNamara Coleen A   Hedelt Anne   Chaney Cherie   Perry Mary Lou   Miller III Thomas M   Tyler Karen D   McCall Anthony L  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.2, Iss.4, 2005-07, pp. : 587-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus

By  

Cardiology, Vol. 135, Iss. 2, 2016-06 ,pp. : 108-126

Karger

Access to resources Recommend Favorite

Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 234-244

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes and cardiovascular disease: time for individualized risk reduction

By McFarlane Samy I   Sowers James R  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 451-453

Future Medicine

Access to resources Recommend Favorite

Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 32, Iss. 7, 2016-10 ,pp. : 685-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of diabetes mellitus among patients with myasthenia gravis

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 2, 2015-08 ,pp. : 132-138

John Wiley & Sons Inc

Access to resources Recommend Favorite